1. The hierarchy of evidence in ADHD treatment
When patients - or parents of patients - ask about "natural" or "non-medication" approaches to ADHD, what they are almost always asking is some version of: can lifestyle do this without drugs? The honest answer requires being precise about effect sizes. Different interventions for ADHD do not produce equivalent benefits. The hierarchy is reasonably well-established in head-to-head meta-analyses, and it looks like this:
| Intervention | Effect size (SMD, core symptoms) | Evidence quality | Best use |
|---|---|---|---|
| Stimulant medication (methylphenidate, amphetamine) | 0.78-1.02 | Network meta-analysis, hundreds of RCTs (Cortese 2018) | First-line for moderate-to-severe ADHD |
| Non-stimulant medication (atomoxetine, guanfacine, viloxazine) | 0.45-0.65 | Network meta-analysis (Cortese 2018) | Second-line, comorbidity, tolerability |
| Exercise (acute aerobic) | 0.40-0.60 | Multiple meta-analyses (Cerrillo-Urbina 2015; Vysniauske 2020) | Universal adjunct |
| CBT for ADHD in adults (added to medication) | 0.40-0.80 (functional) | RCT (Safren & Sprich, JAMA 2010) | Adults on stable medication |
| Behavioral parent training | 0.30-0.50 (parent-rated) | Multiple RCTs (Sonuga-Barke 2013, blinded analysis) | Children with ODD or family conflict |
| ADHD coaching (adults) | 0.50-0.90 (small RCTs) | Limited but growing (Prevatt & Yelland 2015; Field 2013) | Adults needing executive scaffolding |
| Omega-3 supplementation | 0.16-0.31 | Multiple meta-analyses (Bloch & Qawasmi 2011) | Adjunct, low risk |
| Mindfulness/yoga | 0.20-0.45 (mostly attention measures) | Meta-analyses with high heterogeneity | Anxiety comorbidity, emotion regulation |
| Working memory training (CogMed) | ~0 (blinded clinical outcomes) | Negative meta-analyses (Cortese 2015; Sonuga-Barke 2013) | Not recommended for clinical ADHD |
| Neurofeedback | ~0 to small (blinded raters) | Weak; mostly fails blinded-rater test | Not recommended outside research |
Three things stand out from this table. First, the gap between stimulant medication and even the best non-pharmacologic intervention is substantial - roughly two-fold in effect size. Second, when blinded raters are used (the gold standard, because parent and teacher ratings are vulnerable to expectancy effects), the effect sizes for non-pharmacologic interventions consistently shrink. Third, several interventions that are heavily marketed - working memory training, neurofeedback, commercial brain scans - fail when the methodology is tightened.
What this hierarchy does not mean is that lifestyle adjuncts are unimportant. A 0.4 effect size is clinically meaningful. A treatment with SMD 0.4 layered on top of a treatment with SMD 1.0 still adds real benefit, particularly for the functional outcomes (school performance, peer relationships, accidents, occupational outcomes) that pure symptom-rating-scale measures often miss. The point is to weigh each intervention against its actual evidence, not against the marketing claims attached to it.
2. Exercise: the most evidence-based lifestyle adjunct
Of all the non-pharmacologic interventions in ADHD, exercise has the most consistent and largest effect sizes. The mechanism is biologically plausible (acute increases in dopamine, norepinephrine, and BDNF in regions implicated in ADHD; chronic improvements in prefrontal-mediated executive function), and the empirical signal is strong.
Effect sizes
The Cerrillo-Urbina meta-analysis (2015) of randomized controlled trials in children with ADHD found pooled effect sizes of approximately 0.55-0.83 for various exercise modalities on attention, hyperactivity, impulsivity, and executive function. A 2020 update by Vysniauske and colleagues confirmed effect sizes in the 0.40-0.60 range, with acute effects (after a single session) larger than chronic effects (after weeks of training).
Modality and dose
Moderate-to-vigorous aerobic exercise has the most consistent evidence. Mixed-modality programs (aerobic plus motor-coordination challenges) appear similar. Single sessions of 20-30 minutes produce measurable acute improvements in attention and executive function lasting 30-60 minutes. Chronic programs of 30-60 minutes, 3-5 times per week, for at least 6-8 weeks show the largest sustained effects.
When exercise matters most
Three populations gain disproportionately from exercise:
- Children with co-occurring oppositional symptoms who use exercise to discharge motor energy and improve self-regulation
- Adolescents and young adults in school or college settings where pre-class exercise meaningfully improves on-task behavior
- Adults with comorbid mood symptoms, who get the dual benefit of exercise as an antidepressant adjunct
For a deeper dive on dose-response, modality choice, the timing of pre-task exercise, and the limits of the evidence (most studies have been short-duration; chronic effects are smaller and more heterogeneous than acute effects), see the cluster spoke: Exercise for ADHD: What the Evidence Says.
3. Nutrition and supplements
Diet and supplements occupy a strange place in the ADHD literature: heavily commercialized, often over-promised, but with a real (small) effect size when scrutinized rigorously. The honest summary is that no dietary intervention approaches the effect size of stimulant medication, but a few are worth considering as adjuncts.
Omega-3 fatty acids
The meta-analytic estimate is SMD 0.16-0.31 for omega-3 supplementation in pediatric ADHD (Bloch & Qawasmi 2011; subsequent updates). The signal is strongest when:
- The supplement contains predominantly EPA (eicosapentaenoic acid) at >500 mg/day
- Treatment duration is at least 8-12 weeks
- Baseline omega-3 status is low
The effect size is small - roughly one-fourth to one-third of what stimulant medication produces - but the safety profile is excellent and the cost is modest. Omega-3 is a reasonable adjunct, not a substitute.
Iron, zinc, and magnesium
Supplementation is supported only in patients who are actually deficient. Ferritin <30 ng/mL is associated with worse ADHD outcomes and warrants supplementation. Zinc and magnesium deficiency are less common in well-nourished populations but should be measured before empiric supplementation. Routine multi-mineral supplementation in non-deficient children does not have meaningful evidence for ADHD outcomes.
Elimination diets
The "Few Foods" or oligoantigenic elimination diet has shown effect sizes of 0.5-1.0 in some studies (Pelsser et al., Lancet 2011) - large, but the studies are small, methodologically heterogeneous, and very difficult to blind. Even strong supporters of elimination diets concede that they identify a minority of children with food-related ADHD-like symptoms; they are not a general treatment. Implementation is demanding, often disrupts family functioning, and is rarely sustained.
The Mediterranean dietary pattern
Cross-sectional data suggest that adherence to a Mediterranean-style diet is associated with lower ADHD symptom severity in children and adolescents. Whether this is causal or reflects confounding (families that eat Mediterranean diets differ in many other ways) is unsettled. A general recommendation toward Mediterranean-pattern eating is low-cost, low-risk, and has independent benefit for mood, cardiovascular health, and metabolic outcomes.
Sugar and artificial colors
Sugar does not, in randomized challenge studies, increase ADHD symptoms in most children. Artificial food coloring has a small but measurable effect in a subset of children, especially those identified as sensitive on parental report. The effect size is modest and the population effect is small.
For practical guidance on supplementation - including specific doses, what to test, and how to set realistic expectations with families - see Diet and Supplements for ADHD.
4. Behavioral parent training and family interventions
For school-age children with ADHD - especially those with co-occurring oppositional or conduct symptoms - behavioral parent training (BPT) is one of the best-supported non-pharmacologic interventions. The two largest evidence bases are Russell Barkley's behavioral parent training program and Carolyn Webster-Stratton's Incredible Years program, both with decades of RCT support.
What BPT actually teaches
BPT is not generic parenting advice. It is a structured, time-limited curriculum (usually 8-16 weeks) that teaches parents specific contingency-management techniques: clear and consistent commands, predictable consequences, structured reinforcement, planned ignoring of low-stakes behaviors, and time-out procedures. The skills are operationalized and practiced with coaching feedback.
Effect sizes
Sonuga-Barke and colleagues' careful 2013 meta-analysis distinguished between parent/teacher ratings (vulnerable to expectancy effects in non-blinded designs) and blinded outcome assessments. With blinded raters, behavioral interventions had effect sizes of approximately 0.30-0.50 on functional outcomes and a smaller, more variable effect on core ADHD symptoms. The most robust signal is on parent-child interaction quality, child oppositional behavior, and parenting stress - not on the inattention symptoms that medication primarily targets.
When BPT works
- Children with ADHD plus oppositional defiant disorder or significant family conflict
- Families with adequate organizational capacity to implement consistent home structures
- Adjunct to medication, not substitute for it (the MTA study's combination arm outperformed behavior therapy alone)
When BPT fails
- Families dealing with active parental psychopathology (depression, untreated parental ADHD, substance use) - the parent may not be able to implement consistent strategies
- Families with severe psychosocial adversity (poverty, housing instability, domestic violence)
- Adolescents - BPT is largely a school-age intervention; for teenagers, the parallel evidence base is family-based therapy and contingency contracting, with effect sizes that diminish with age
One of the under-discussed obstacles to BPT is that ADHD is highly heritable: a meaningful proportion of parents of children with ADHD have ADHD themselves, often undiagnosed and untreated. Implementing a behavioral contingency program requires consistency and follow-through - exactly the executive-function tasks that ADHD impairs. For deeper discussion of how parental ADHD affects parenting interventions, see Parenting with ADHD When Your Child Has ADHD and the foundational ADHD Genetics and Heritability review.
5. ADHD coaching
ADHD coaching is a fast-growing field that occupies a different niche than psychotherapy. Coaches focus on executive function, organization, time management, and accountability - the practical skills of living with ADHD. They are not therapists; they do not treat psychiatric disorders. The relevant question is whether structured coaching, beyond what a friend or family member can provide, improves outcomes.
What the evidence shows
The literature is small but encouraging. Prevatt and Yelland (2015) randomized 145 college students with ADHD to an 8-session structured coaching protocol versus wait-list control and found medium-to-large effects on learning and study strategies, well-being, and self-regulation. Field, Parker, Sawilowsky, and Rolands (2013) found similar magnitudes in college students. The effect sizes in these studies are in the 0.5-0.9 range - larger than the parent-training literature would suggest - but the trials are small, the populations are selected (motivated college students), and replication outside academic settings is limited.
What coaching actually is
A good ADHD coach does not "treat" ADHD - they help the patient build external scaffolding. Typical interventions include:
- Weekly accountability sessions with concrete goal-setting
- Time-management system design (calendars, reminders, environmental cues)
- Task initiation strategies for procrastinated work
- Breaking down complex goals into executive-function-friendly subtasks
- Identifying and addressing avoidance patterns
How to evaluate a coach
ADHD coaching is unregulated. There is no licensure, no scope-of-practice protection, and no required training. Practical questions to ask:
- Did they complete an established coach-training program (e.g., ADD Coach Academy, JST Coaching)?
- Do they hold credentials from the International Coach Federation or the Professional Association of ADHD Coaches (PAAC)?
- Do they have a defined approach with measurable goals, or is the work open-ended?
- Do they recognize when a patient needs psychotherapy or medication evaluation rather than coaching?
The line between coaching, CBT, and ADHD therapy is sometimes thin. For an explicit comparison of the three, see ADHD Coaching, Therapy, and Medication: How They Differ, and for the broader landscape of therapy modalities used in ADHD, see ADHD Therapy Comparison.
6. CBT and therapy for ADHD
CBT for ADHD is a different intervention from CBT for depression or anxiety. The cognitive distortions targeted in mood disorders are not the primary issue in ADHD. CBT for ADHD targets specific executive-function skills - planning, organization, task initiation, delaying impulsive responses, managing procrastination - using behavioral techniques borrowed from broader cognitive-behavioral practice. The most widely studied protocol is Safren and Sprich's manualized program.
The Safren and Sprich evidence
Safren, Sprich, and colleagues published a randomized controlled trial in JAMA (2010) comparing CBT to relaxation-with-educational-support in 86 adults with ADHD on stable medication who continued to have residual symptoms. The CBT arm had significantly greater improvement in both blinded-clinician-rated ADHD symptoms and functional outcomes. The effect size was medium-to-large. Subsequent trials have largely replicated this finding.
What CBT for ADHD looks like
Typical protocols run 12-15 weekly sessions and cover modules on:
- Psychoeducation about ADHD's neurobiology and executive function
- Organization and planning systems (calendars, task lists, prioritization)
- Reducing distractibility (environmental modifications, attention re-direction)
- Adaptive thinking (challenging the maladaptive cognitions that frequently accumulate around chronic underperformance)
- Procrastination and task initiation strategies
Who benefits most
CBT for ADHD is most clearly evidence-based for adults with ADHD who are already on stable pharmacotherapy and continue to have residual symptoms or functional impairment. In children, the data are weaker - school-age children rarely have the metacognitive capacity that CBT requires, and behavioral parent training is the better-supported intervention for that age group.
For a side-by-side review of CBT, DBT, behavioral therapy, family therapy, and coaching as they apply to ADHD, see ADHD Therapy Comparison and the related guide on ADHD Alternative Treatments.
7. Sleep hygiene as treatment
Sleep is the single most underdiagnosed contributor to apparent ADHD severity. Up to 70% of children and a similar proportion of adults with ADHD have a comorbid sleep problem: delayed sleep phase syndrome, restless legs syndrome, periodic limb movements, obstructive sleep apnea, or chronic insufficient sleep. Each of these can independently produce the daytime inattention, irritability, and executive dysfunction that look like ADHD.
The treatment-of-sleep-first principle
A clinical principle I emphasize repeatedly: before titrating ADHD medication, evaluate and treat obvious sleep pathology. In a meaningful minority of cases, the apparent "ADHD" substantially improves once a delayed sleep phase is corrected or an undiagnosed obstructive sleep apnea is treated. This is not a small effect. CPAP therapy for moderate-to-severe OSA can produce dramatic improvements in apparent attention and executive function, even in patients who carry an ADHD diagnosis.
The overlap with sleep apnea
Obstructive sleep apnea in adults can mimic ADHD in nearly every respect: inattention, executive dysfunction, mood instability, irritability, and (counterintuitively) hyperactivity in children. Pediatric OSA is more often caused by adenotonsillar hypertrophy and presents with hyperactivity rather than excessive sleepiness. Any new evaluation for adult ADHD should include a sleep screen, and any pediatric ADHD evaluation should include questions about snoring, witnessed apneas, and morning headaches. For a detailed comparison and differential, see ADHD versus Sleep Apnea: How to Tell Them Apart.
Sleep hygiene interventions
For patients without primary sleep pathology, basic sleep hygiene is a low-cost adjunct with meaningful clinical impact:
- Consistent sleep and wake times, even on weekends
- Reduced screen and stimulant exposure 1-2 hours before bed
- Cool, dark, quiet sleep environment
- Limiting late-day caffeine; stimulant ADHD medication timing optimized to avoid sleep-onset interference
- Cognitive-behavioral therapy for insomnia (CBT-I) when there is true comorbid insomnia
For deeper discussion of the bidirectional relationship between ADHD and sleep, see ADHD and Sleep.
8. Mindfulness, meditation, and yoga
Mindfulness-based interventions for ADHD have generated enthusiastic uptake and a moderate research literature. The pooled effect sizes are small but real, with high methodological heterogeneity.
What the evidence shows
Meta-analyses of mindfulness-based interventions for ADHD report effect sizes of approximately 0.20-0.45 on attention measures and self-report symptom scales. Most of the signal is on self-rated emotional regulation and attention, with weaker effects on blinded behavioral outcomes. Mindfulness Awareness Practices for ADHD (MAPs) and Mindfulness-Based Stress Reduction (MBSR) are the most-studied protocols.
What mindfulness helps
- Emotion regulation in adults with ADHD and the emotional dysregulation that frequently accompanies it
- Anxiety comorbidity - mindfulness has independent evidence for anxiety reduction
- Meta-awareness - the ability to notice attentional drift and re-direct it, which is the foundational ADHD executive skill
What mindfulness does not help
- Core hyperactivity and impulsivity in children - the mainstay of behavioral and pharmacologic intervention
- Acute task performance under cognitive load - the acute effect of exercise on attention is larger and more reliable
- Functional outcomes (school performance, job retention) - the evidence is sparse
Yoga has a small parallel literature with similar effect sizes and similar methodological concerns. The practical recommendation: mindfulness and yoga are reasonable, low-risk adjuncts for adults and older adolescents with ADHD - particularly those with comorbid anxiety or emotion dysregulation - but they are not first-line treatments for the core symptoms.
9. Time management systems and external scaffolding
One of the most clinically useful framings in ADHD is the distinction between internal regulation (will, motivation, discipline) and external scaffolding (systems, environmental cues, accountability structures). ADHD impairs internal regulation. The most effective practical response is not to demand more internal regulation but to design external scaffolding that makes the desired behavior the path of least resistance.
What external scaffolding looks like
- Calendars and reminders for everything - not as memory aids but as offloaded executive function
- Visible time - analog clocks, time-blocking, visible countdowns - because ADHD time blindness is a real perceptual deficit, not a moral failing
- Environmental triggers - clothes laid out the night before, medication next to the toothbrush, gym bag at the door
- Body doubling - working alongside another person, in person or remote, as an external accountability cue
- Habit stacking - chaining new behaviors onto established routines so that the existing trigger pulls the new behavior
- Reduced friction for the desired behavior; increased friction for the avoided behavior (phone in another room, browser blockers, single-tasking environments)
Time blindness - the impaired sense of how time is passing - is one of the most disabling features of ADHD and one of the most amenable to scaffolding. Patients consistently report that making time visible (with timers, time-tracking apps, calendar blocking) produces meaningful improvement in task completion. For detailed strategies, see ADHD Time Blindness and What to Do About It.
The corollary is that for many adults with ADHD, the cumulative cost of compensating - constant masking, over-functioning, and post-hoc damage control - produces a distinct pattern of burnout. The ADHD burnout pattern in high achievers is one of the most under-recognized clinical presentations in adult psychiatry, and addressing it often requires reducing the masking burden, not adding more compensation. See also ADHD Masking and Unmasking.
10. What does NOT work: the debunk section
Some interventions for ADHD generate substantial commercial revenue without commensurate evidence. Patients and parents are entitled to know which.
Working memory training (CogMed, Lumosity, and similar)
Working memory training improves performance on the specific tasks practiced. It does not generalize to clinical ADHD symptoms, academic performance, or daily functional outcomes when measured by blinded raters. This conclusion is consistent across multiple meta-analyses (Cortese et al. 2015; Sonuga-Barke et al. 2013; Melby-Lervag & Hulme 2013). The on-task improvements are real but they are domain-specific. CogMed and similar programs are not supported as treatments for clinical ADHD.
Neurofeedback
Neurofeedback has been studied for decades. The most methodologically rigorous trials - with sham-controlled, double-blind designs and blinded raters - have found minimal-to-no benefit on clinical ADHD outcomes. Some open-label or non-blinded studies suggest benefit, but the size of the effect collapses when blinding is enforced. Neurofeedback is not recommended outside research settings.
Commercial brain scans (SPECT, qEEG) for ADHD diagnosis or treatment-matching
Several high-profile commercial services claim to diagnose or sub-type ADHD based on SPECT, qEEG, or other imaging modalities. The science does not support this. While group-level neuroimaging differences exist in ADHD (and continue to be characterized in 2026 brain-scan subtype literature), they do not have the sensitivity or specificity to diagnose ADHD at the individual level, nor do they reliably predict treatment response. For a detailed discussion of what brain-scan subtype research actually shows and does not show, see ADHD Brain Subtypes 2026: What the New Imaging Literature Does and Doesn't Tell Us.
Most "brain-training" apps
The Federal Trade Commission has taken enforcement action against several brain-training app companies (including Lumosity) for unsubstantiated cognitive-improvement claims. The general pattern - improvement on trained tasks, no generalization to real-world function - holds.
Megavitamin therapy and proprietary supplement blends
High-dose vitamin and proprietary blend regimens (often marketed for "natural" ADHD treatment) lack supporting evidence and can cause harm at high doses. Omega-3 and targeted correction of documented deficiency are the only supplement interventions with respectable evidence.
11. The combination principle
The most important conceptual point in this entire review is that the question is rarely "medication or lifestyle." The question is which combination produces the best outcome for a given patient. The MTA Cooperative Group's landmark 14-month randomized trial (1999) found that medication plus behavior therapy was superior to either alone for many secondary outcomes - parent satisfaction, comorbid oppositional symptoms, family functioning - even when medication alone was equivalent or superior on core ADHD symptoms.
The general pattern across the literature:
- Medication alone produces the largest effect on core inattention and hyperactivity-impulsivity symptoms.
- Behavioral therapy alone produces smaller effects on core symptoms but meaningful effects on functional outcomes, comorbid problems, and family functioning.
- Combination treatment consistently produces the broadest improvement across symptom, functional, and family domains.
- Lifestyle adjuncts (exercise, sleep, omega-3, mindfulness) add incremental benefit and address comorbidities that medication alone does not target.
The clinical question is not which to choose. It is the order of operations.
12. A practical clinician's framework
The order of operations I use in clinical practice when assessing and treating ADHD is, roughly:
| Step | What I'm doing | Why it's first |
|---|---|---|
| 1. Diagnose carefully | Structured history, validated rating scales (Vanderbilt, ASRS, Conners), collateral information from school or partner, differential for mimics (anxiety, depression, trauma, learning disability, sleep disorder, substance use) | Most failures of ADHD treatment start with diagnostic imprecision. |
| 2. Screen and treat sleep | Ask about sleep onset, duration, snoring, restless legs, daytime sleepiness; refer for polysomnography if OSA is suspected; address delayed sleep phase | Untreated sleep disorders mimic and worsen ADHD; treating them often substantially reduces apparent ADHD severity. |
| 3. Address comorbidity | Treat major depression, severe anxiety, or active substance use that may complicate or contraindicate stimulant therapy; identify oppositional, conduct, or trauma-related symptoms that need their own treatment plan | 69.5% of adolescents with ADHD have at least one comorbid disorder (Sultan 2021); these conditions often need parallel treatment. |
| 4. Stabilize pharmacotherapy | Initiate evidence-based stimulant or non-stimulant; titrate to a clinically meaningful response with manageable side effects; reassess at 4-8 weeks | Medication produces the largest single effect; later adjuncts work better against a stable medication baseline. |
| 5. Layer in exercise and sleep hygiene | Concrete, dose-specific recommendations - 30-60 min moderate-vigorous activity 4-5x/week; consistent sleep schedule; targeted sleep hygiene if relevant | Universal adjuncts with the broadest benefit-to-burden ratio. |
| 6. Add behavioral and skills-based therapy | For children: behavioral parent training; for adolescents: family-based intervention; for adults: CBT for ADHD or coaching, depending on need and access | Most cost-effective targeted therapy for functional outcomes. |
| 7. Optimize external scaffolding | Calendar systems, time-visibility tools, environmental redesign, body doubling, accountability structures | Compensates for the executive-function deficits that medication does not fully resolve. |
| 8. Consider supplements (selectively) | Omega-3 (EPA-predominant, >500 mg/day) as adjunct; check ferritin and replace iron if <30 ng/mL | Modest but real benefit; minimal harm. |
| 9. Re-evaluate | Every 3-6 months: symptom scales, functional outcomes, side effects, comorbidity, family functioning. Adjust. | ADHD is a chronic condition; treatment needs evolve. |
The framework applies the same logic across age groups, with the specific adjuncts varying: behavioral parent training is central in school-age, family-based therapy in adolescence, CBT and coaching in adulthood. Exercise, sleep, and external scaffolding are universal.
For a deeper, treatment-side discussion of how pharmacotherapy changes the natural course of ADHD - including cardiovascular safety, substance-use considerations, and pediatric prescribing - see ADHD Pharmacology & Natural Course. For the population-level evidence on what happens when ADHD goes untreated, see Adverse Outcomes of Untreated ADHD. For the women's-health-specific considerations that interact heavily with lifestyle adjuncts, see ADHD in Women.
13. Frequently asked questions
Can lifestyle changes replace ADHD medication?
For most people with moderate-to-severe ADHD, no. Stimulant medication has an effect size approximately two to three times larger than the highest-evidence lifestyle interventions. Lifestyle adjuncts are valuable complements but rarely substitutes.
What is the most evidence-based lifestyle intervention for ADHD?
Exercise. Acute aerobic exercise has effect sizes of approximately 0.4-0.6 on attentional and executive performance. Moderate-to-vigorous aerobic activity, mixed with motor-coordination challenges, has the most consistent evidence.
Do omega-3 fatty acids help with ADHD?
Modestly. Meta-analyses show effect sizes of 0.16-0.31, strongest when the supplement is EPA-predominant at >500 mg/day. Real, reproducible, well-tolerated - but small.
Does ADHD coaching actually work?
The evidence base is small but encouraging. Small RCTs show medium-to-large effect sizes on executive function in college students and adults. Coaching is unregulated, so practitioner quality varies enormously. Best as an adjunct for adults already on stable medication.
Is CBT effective for ADHD?
Yes, especially for adults already on stable medication. The Safren and Sprich RCT (JAMA 2010) showed medium-to-large effect sizes when CBT was added to pharmacotherapy.
Should I treat sleep before treating ADHD?
Often, yes. Up to 70% of patients with ADHD have a comorbid sleep problem. A clinical principle is to evaluate and address obvious sleep pathology before titrating ADHD medication.
Does working memory training (CogMed, brain training apps) help ADHD?
No, not for clinical ADHD outcomes. Improvement is task-specific and does not generalize to real-world function when measured by blinded raters.
What is the best combination of treatments for ADHD?
There is no single best combination. The general principle is to stabilize medication first, then layer evidence-based behavioral and lifestyle adjuncts based on the patient's specific impairments and comorbidities.
14. Primary references
- Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit/hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727-738. doi:10.1016/S2215-0366(18)30269-4
- Cerrillo-Urbina AJ, Garcia-Hermoso A, Sanchez-Lopez M, Pardo-Guijarro MJ, Santos Gomez JL, Martinez-Vizcaino V. The effects of physical exercise in children with attention deficit hyperactivity disorder: a systematic review and meta-analysis of randomized control trials. Child Care Health Dev. 2015;41(6):779-788. doi:10.1111/cch.12255
- Vysniauske R, Verburgh L, Oosterlaan J, Molendijk ML. The effects of physical exercise on functional outcomes in the treatment of ADHD: a meta-analysis. J Atten Disord. 2020;24(5):644-654. doi:10.1177/1087054715627489
- Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2011;50(10):991-1000. doi:10.1016/j.jaac.2011.06.008
- Pelsser LM, Frankena K, Toorman J, et al. Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial. Lancet. 2011;377(9764):494-503. doi:10.1016/S0140-6736(10)62227-1
- Safren SA, Sprich S, Mimiaga MJ, et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA. 2010;304(8):875-880. doi:10.1001/jama.2010.1192
- MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1073-1086. doi:10.1001/archpsyc.56.12.1073
- Sonuga-Barke EJS, Brandeis D, Cortese S, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013;170(3):275-289. doi:10.1176/appi.ajp.2012.12070991
- Cortese S, Ferrin M, Brandeis D, et al. Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. J Am Acad Child Adolesc Psychiatry. 2015;54(3):164-174. doi:10.1016/j.jaac.2014.12.010
- Prevatt F, Yelland S. An empirical evaluation of ADHD coaching in college students. J Atten Disord. 2015;19(8):666-677. doi:10.1177/1087054713480036
- Field S, Parker DR, Sawilowsky S, Rolands L. Assessing the impact of ADHD coaching services on university students' learning skills, self-regulation, and well-being. J Postsecondary Educ Disabil. 2013;26(1):67-81.
- Sultan RS, Liu SM, Hacker KA, Olfson M. Adolescents With Attention-Deficit/Hyperactivity Disorder: Adverse Behaviors and Comorbidity. J Adolesc Health. 2021;68(2):284-291. doi:10.1016/j.jadohealth.2020.09.036
- Melby-Lervag M, Hulme C. Is working memory training effective? A meta-analytic review. Dev Psychol. 2013;49(2):270-291. doi:10.1037/a0028228
15. Further reading: cluster 8 spokes and adjacent clusters
Lifestyle & treatment adjuncts (Cluster 8)
- Exercise for ADHD: What the Evidence Says
- Diet and Supplements for ADHD
- Parenting with ADHD When Your Child Has ADHD
- ADHD Time Blindness and What to Do About It
- ADHD Coaching, Therapy, and Medication
- ADHD Therapy Comparison
- ADHD Alternative Treatments
- ADHD and Sleep
- ADHD versus Sleep Apnea
- ADHD Burnout in High Achievers
- ADHD Masking and Unmasking
Adjacent clusters and pillar pages
Considering an evidence-based ADHD treatment plan?
Dr. Sultan provides ADHD evaluation and pharmacologic management at Columbia University Medical Center in New York City. Lifestyle adjuncts are layered onto a stabilized medication regimen, not used as substitutes.
Request Consultation Read: Pharmacology & Natural CourseAbout Dr. Ryan Sultan
Dr. Ryan Sultan is Assistant Professor of Clinical Psychiatry at Columbia University Irving Medical Center, Director of the Sultan Lab for Mental Health Informatics, and double board-certified in Adult Psychiatry and Child & Adolescent Psychiatry. He is an expert in ADHD and psychopharmacology - including pediatric and adolescent prescribing - and has authored the field's most-cited recent work on the population-level burden of untreated ADHD and the protective effects of pharmacotherapy on real-world outcomes.
His clinical and academic interests focus on how to weigh evidence carefully across pharmacologic and non-pharmacologic interventions in ADHD. He holds an NIH NIDA K12 award and is the senior author of the 2019 JAMA Network Open study on antipsychotic use in youth with ADHD (440+ citations), the 2021 J Adolesc Health paper on adolescents with ADHD and adverse behavioral outcomes, and the 2025 JAMA Psychiatry editorial on the protective effects of ADHD medication.